Revvity Operating Margin 2010-2025 | RVTY
Current and historical operating margin for Revvity (RVTY) over the last 10 years. The current operating profit margin for Revvity as of March 31, 2025 is 21.70%.
| Revvity Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $2.77B | $0.38B | 13.54% |
| 2024-12-31 | $2.76B | $0.35B | 12.60% |
| 2024-09-30 | $2.72B | $0.31B | 11.20% |
| 2024-06-30 | $2.71B | $0.28B | 10.19% |
| 2024-03-31 | $2.73B | $0.27B | 9.83% |
| 2023-12-31 | $2.75B | $0.30B | 10.91% |
| 2023-09-30 | $2.80B | $0.36B | 12.88% |
| 2023-06-30 | $2.84B | $0.40B | 14.17% |
| 2023-03-31 | $3.02B | $0.56B | 18.39% |
| 2022-12-31 | $3.31B | $0.74B | 22.40% |
| 2022-09-30 | $3.00B | $0.87B | 28.92% |
| 2022-06-30 | $3.15B | $0.95B | 30.25% |
| 2022-03-31 | $3.48B | $1.05B | 30.24% |
| 2021-12-31 | $3.83B | $1.26B | 32.90% |
| 2021-09-30 | $3.63B | $1.40B | 38.41% |
| 2021-06-30 | $3.74B | $1.45B | 38.74% |
| 2021-03-31 | $3.32B | $1.29B | 38.90% |
| 2020-12-31 | $2.66B | $0.87B | 32.59% |
| 2020-09-30 | $3.23B | $0.61B | 18.78% |
| 2020-06-30 | $2.98B | $0.44B | 14.72% |
| 2020-03-31 | $2.89B | $0.35B | 12.26% |
| 2019-12-31 | $2.88B | $0.36B | 12.55% |
| 2019-09-30 | $2.84B | $0.34B | 11.99% |
| 2019-06-30 | $2.80B | $0.34B | 12.17% |
| 2019-03-31 | $2.78B | $0.34B | 12.11% |
| 2018-12-31 | $2.78B | $0.32B | 11.67% |
| 2018-09-30 | $2.66B | $0.30B | 11.34% |
| 2018-06-30 | $2.54B | $0.30B | 11.80% |
| 2018-03-31 | $2.39B | $0.29B | 11.98% |
| 2017-12-31 | $2.26B | $0.30B | 13.11% |
| 2017-09-30 | $2.18B | $0.29B | 13.47% |
| 2017-06-30 | $2.14B | $0.29B | 13.63% |
| 2017-03-31 | $2.13B | $0.28B | 13.33% |
| 2016-12-31 | $2.12B | $0.30B | 13.95% |
| 2016-09-30 | $2.00B | $0.25B | 12.66% |
| 2016-06-30 | $2.05B | $0.25B | 12.35% |
| 2016-03-31 | $2.08B | $0.26B | 12.28% |
| 2015-12-31 | $2.11B | $0.25B | 11.92% |
| 2015-09-30 | $2.10B | $0.19B | 8.88% |
| 2015-06-30 | $2.07B | $0.17B | 8.15% |
| 2015-03-31 | $2.07B | $0.17B | 8.28% |
| 2014-12-31 | $2.07B | $0.17B | 8.02% |
| 2014-09-30 | $2.22B | $0.28B | 12.40% |
| 2014-06-30 | $2.20B | $0.27B | 12.47% |
| 2014-03-31 | $2.18B | $0.24B | 11.18% |
| 2013-12-31 | $2.16B | $0.23B | 10.57% |
| 2013-09-30 | $2.13B | $0.11B | 5.07% |
| 2013-06-30 | $2.12B | $0.09B | 4.39% |
| 2013-03-31 | $2.10B | $0.10B | 4.90% |
| 2012-12-31 | $2.11B | $0.10B | 4.89% |
| 2012-09-30 | $2.08B | $0.10B | 4.95% |
| 2012-06-30 | $2.03B | $0.10B | 4.74% |
| 2012-03-31 | $1.98B | $0.09B | 4.29% |
| 2011-12-31 | $1.92B | $0.09B | 4.69% |
| 2011-09-30 | $1.85B | $0.17B | 9.10% |
| 2011-06-30 | $1.81B | $0.17B | 9.55% |
| 2011-03-31 | $1.76B | $0.17B | 9.52% |
| 2010-12-31 | $1.70B | $0.16B | 9.22% |
| 2010-09-30 | $1.54B | $0.14B | 8.86% |
| 2010-06-30 | $1.49B | $0.12B | 7.84% |
| 2010-03-31 | $1.51B | $0.12B | 8.08% |
| 2009-12-31 | $1.55B | $0.12B | 7.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.024B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.613B | 26.94 |
| Elevance Health (ELV) | United States | $86.883B | 11.21 |
| CVS Health (CVS) | United States | $85.338B | 10.61 |
| Cencora (COR) | United States | $57.283B | 19.93 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.577B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.856B | 17.73 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.669B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.52 |
| ICON (ICLR) | Ireland | $11.763B | 10.94 |
| CochLear (CHEOY) | Australia | $11.550B | 0.00 |
| Doximity (DOCS) | United States | $10.503B | 48.63 |
| Viatris (VTRS) | United States | $10.469B | 3.60 |
| HealthEquity (HQY) | United States | $9.059B | 39.68 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.572B | 22.77 |
| Sonic Healthcare (SKHHY) | Australia | $8.393B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.340B | 14.38 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.361B | 25.69 |
| BrightSpring Health Services (BTSG) | United States | $3.724B | 34.16 |
| Sotera Health (SHC) | United States | $3.244B | 18.43 |
| Alignment Healthcare (ALHC) | United States | $2.956B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.914B | 37.90 |
| Concentras Parent (CON) | United States | $2.749B | 15.89 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Ardent Health (ARDT) | United States | $1.881B | 8.02 |
| Premier (PINC) | United States | $1.858B | 14.11 |
| GeneDx Holdings (WGS) | United States | $1.842B | 70.96 |
| Progyny (PGNY) | United States | $1.803B | 39.68 |
| PACS (PACS) | United States | $1.573B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.561B | 31.21 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.203B | 9.15 |
| Establishment Labs Holdings (ESTA) | $1.083B | 0.00 | |
| CareDx (CDNA) | United States | $1.035B | 16.17 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.826B | 7.73 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 10.28 |
| LifeMD (LFMD) | United States | $0.566B | 0.00 |
| Embecta (EMBC) | United States | $0.559B | 3.76 |
| Enhabit (EHAB) | United States | $0.495B | 40.75 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| SBC Medicals (SBC) | United States | $0.459B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.453B | 0.00 |
| Omada Health (OMDA) | $0.440B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.411B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.255B | 0.00 |
| Oncology Institute (TOI) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.114B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| KindlyMD (NAKA) | United States | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |